Now showing items 1-10 of 61
Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review.
(African Health Sciences, 2014)
The effectiveness of combination antiretroviral therapy (cART) continues to improve as treatment choices expand with the development of new antiretroviral agents and regimens. However, the successful long-term treatment ...
Trends in hepatitis B virus testing practices and management in HIV clinics across sub- Saharan Africa
(BMC infectious diseases, 2017)
Approximately 8% of HIV-infected individuals are co-infected with hepatitis B virus (HBV) in sub-Saharan Africa (SSA). Knowledge of HBV status is important to guide optimal selection of antiretroviral therapy (ART) ...
Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda
(African health sciences, 2008)
In Uganda, as in many other parts of the world cancer of the oesophagus (CAE) is on the rise. Squamous cell carcinoma and adenocarcinoma are the common subtypes. Risk factors for this cancer have been identified but not ...
Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda
(Afri Health Sci, 2015)
There is a paucity of published data regarding upper gastrointestinal diseases in Ugandans with upper gastrointestinal symptoms referred for endoscopy. Objectives: To study the presenting complaints, pathology and ...
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
(Liver International,, 2011)
Most of the estimated 350 million people with chronic hepatitis B virus (HBV) infection live in resource-constrained settings. Up to 25% of those persons will die prematurely of hepatocellular carcinoma (HCC) or cirrhosis. ...
Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors
(BMC complementary medicine and therapies, 2020)
There is some evidence that patients with liver diseases commonly use complementary and alternative therapies to address general and liver-disease specific health concerns. The purpose of this study was to assess and ...
Hepatitis B virus infection: current status
Hepatitis B virus currently affects more than 400 million people world wide. Despite the availability of Hepatitis B vaccine, the overall prevalence of Hepatitis B infection has declined little in recent years.
Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences
(PLOS ONE, 2019-04-05)
Abstract Background Hepatitis B is a global health problem. Trainees in the health-related fields are exposed to occupational risk of Hepatitis B Virus. In Uganda, there is scarcity of information on vaccination among ...
The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda
(African health sciences, 2008)
Liver diseases are common in patients with HIV due to viral hepatitis B and C co-infections, opportunistic infections or malignancies, antiretroviral drugs and drugs for opportunistic infections. Objective: To describe ...
The burden, pattern and factors that contribute to periportal fibrosis in HIV-infected patients in an S. mansoni endemic rural Uganda.
(African Health Sciences, 2017)
Both Human Immunodeficiency Virus (HIV) and S.mansoni infections are common in Uganda and can cause liver disease. No study has determined co-infection significance in Uganda. We carried out a study on the burden, pattern ...